192 related articles for article (PubMed ID: 7591633)
1. In vivo inhibition of lens regrowth by fibroblast growth factor 2-saporin.
Behar-Cohen FF; David T; D'Hermies F; Pouliquen YM; Buechler Y; Nova MP; Houston LL; Courtois Y
Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2434-48. PubMed ID: 7591633
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of FGF2-saporin on bovine epithelial lens cells in vitro.
Behar-Cohen FF; David T; Buechler Y; Nova MP; Houston LL; Pouliquen YM; Courtois Y
Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2425-33. PubMed ID: 7591632
[TBL] [Abstract][Full Text] [Related]
3. Biphasic effect of the mitotoxin bFGF-saporin on bovine lens epithelial cell growth: effect of cell density and extracellular matrix.
David T; Tassin J; Lappi DA; Baird A; Courtois Y
J Cell Physiol; 1992 Dec; 153(3):483-90. PubMed ID: 1447311
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative effect of basic fibroblast growth factor-saporin mitotoxin on keratocytes in culture.
Wee WR; Parandoosh Z; Sakamoto T; Caton M; Nova M; McDonnell PJ
Korean J Ophthalmol; 1996 Jun; 10(1):1-7. PubMed ID: 8755195
[TBL] [Abstract][Full Text] [Related]
5. The role of exogenous/endogenous basic fibroblast growth factor (FGF2) and transforming growth factor beta (TGF beta-1) on human corneal endothelial cells proliferation in vitro.
Rieck P; Oliver L; Engelmann K; Fuhrmann G; Hartmann C; Courtois Y
Exp Cell Res; 1995 Sep; 220(1):36-46. PubMed ID: 7664841
[TBL] [Abstract][Full Text] [Related]
6. A study of human lens cell growth in vitro. A model for posterior capsule opacification.
Liu CS; Wormstone IM; Duncan G; Marcantonio JM; Webb SF; Davies PD
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):906-14. PubMed ID: 8603875
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo.
Beitz JG; Davol P; Clark JW; Kato J; Medina M; Frackelton AR; Lappi DA; Baird A; Calabresi P
Cancer Res; 1992 Jan; 52(1):227-30. PubMed ID: 1309225
[TBL] [Abstract][Full Text] [Related]
8. Use of a polylysine-saporin conjugate to prevent posterior capsule opacification.
Bretton RH; Swearingen A; Kash RL; Cooley R
J Cataract Refract Surg; 1999 Jul; 25(7):921-9. PubMed ID: 10404366
[TBL] [Abstract][Full Text] [Related]
9. Selenium functionalized intraocular lenses inhibit posterior capsule opacification in an ex vivo canine lens capsular bag assay.
Pot SA; Chandler HL; Colitz CM; Bentley E; Dubielzig RR; Mosley TS; Reid TW; Murphy CJ
Exp Eye Res; 2009 Nov; 89(5):728-34. PubMed ID: 19583956
[TBL] [Abstract][Full Text] [Related]
10. Vascular smooth muscle cell cytotoxicity and sustained inhibition of neointimal formation by fibroblast growth factor 2-saporin fusion protein.
Farb A; Lee SJ; Min DH; Parandoosh Z; Cook J; McDonald J; Pierce GF; Virmani R
Circ Res; 1997 Apr; 80(4):542-50. PubMed ID: 9118485
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures.
Chen C; Li J; Micko CJ; Pierce GF; Cunningham MR; Lumsden AB
J Surg Res; 1998 Feb; 75(1):35-41. PubMed ID: 9614854
[TBL] [Abstract][Full Text] [Related]
12. Local infusion of FGF-saporin reduces intimal hyperplasia.
Mattar SG; Hanson SR; Pierce GF; Chen C; Hughes JD; Cook JE; Shen C; Noe BA; Suwyn CR; Scott JR; Lumsden AB
J Surg Res; 1996 Feb; 60(2):339-44. PubMed ID: 8598665
[TBL] [Abstract][Full Text] [Related]
13. Heparin surface-modified intraocular lenses in patients with inactive uveitis or diabetes.
Tabbara KF; Al-Kaff AS; Al-Rajhi AA; Al-Mansouri SM; Badr IA; Chavis PS; Al-Omar OM
Ophthalmology; 1998 May; 105(5):843-5. PubMed ID: 9593384
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta2-induced matrix modification and cell transdifferentiation in the human lens capsular bag.
Wormstone IM; Tamiya S; Anderson I; Duncan G
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2301-8. PubMed ID: 12091431
[TBL] [Abstract][Full Text] [Related]
15. The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor.
Lappi DA; Maher PA; Martineau D; Baird A
J Cell Physiol; 1991 Apr; 147(1):17-26. PubMed ID: 1645359
[TBL] [Abstract][Full Text] [Related]
16. Opacification of the posterior capsule.
Green WR; McDonnell PJ
Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 7)():727-39. PubMed ID: 3868213
[TBL] [Abstract][Full Text] [Related]
17. Large-scale purification and characterization of recombinant fibroblast growth factor-saporin mitotoxin.
McDonald JR; Ong M; Shen C; Parandoosh Z; Sosnowski B; Bussell S; Houston LL
Protein Expr Purif; 1996 Aug; 8(1):97-108. PubMed ID: 8812840
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 2: roles of regulation of lens cell proliferation and epithelial-mesenchymal transition in response to injury.
Tanaka T; Saika S; Ohnishi Y; Ooshima A; McAvoy JW; Liu CY; Azhar M; Doetschman T; Kao WW
Mol Vis; 2004 Jul; 10():462-7. PubMed ID: 15273655
[TBL] [Abstract][Full Text] [Related]
19. [Cellular response one year after extracapsular cataract extraction--comparison of regular and heparin surface modified PMMA intraocular lenses].
Petrus M; Czajkowski G
Klin Oczna; 2000; 102(3):165-8. PubMed ID: 11126169
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of a homogeneous chemical conjugate between basic fibroblast growth factor and saporin.
Buechler YJ; Sosnowski BA; Victor KD; Parandoosh Z; Bussell SJ; Shen C; Ryder M; Houston LL
Eur J Biochem; 1995 Dec; 234(3):706-13. PubMed ID: 8575426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
